Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Eye Disease (TED)”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Large-scale testing (Phase 3)Study completedNCT05176639
What this trial is testing

A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 113
Post-approval studies (Phase 4)Looking for participantsNCT06927375
What this trial is testing

A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of Thyroid-Associated Ophthalmopathy

Who this might be right for
Thyroid-Associated Ophthalmopathy
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 60
Large-scale testing (Phase 3)Study completedNCT06021054
What this trial is testing

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 188
Not applicableStudy completedNCT07056114
What this trial is testing

Multi-modal Medical Images for Extraocular Muscle Fibrosis Assessment

Who this might be right for
Thyroid Eye Disease, TED
Tianjin Eye Hospital 58
Large-scale testing (Phase 3)Active Not RecruitingNCT06812325
What this trial is testing

A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease (TED)
Viridian Therapeutics, Inc. 320
Large-scale testing (Phase 3)UnknownNCT05015127
What this trial is testing

Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease

Who this might be right for
Thyroid Ophthalmopathy
Harbour BioMed (Guangzhou) Co. Ltd. 36
Large-scale testing (Phase 3)Ended earlyNCT04737330
What this trial is testing

The Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves Orbitopathy
Novartis Pharmaceuticals 28
Testing effectiveness (Phase 2)Study completedNCT05683496
What this trial is testing

Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
ACELYRIN Inc. 31
Large-scale testing (Phase 3)Active Not RecruitingNCT06625398
What this trial is testing

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 204
Large-scale testing (Phase 3)WithdrawnNCT02393183
What this trial is testing

The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Iran University of Medical Sciences
Testing effectiveness (Phase 2)Active Not RecruitingNCT06401044
What this trial is testing

AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Amgen 94
Testing effectiveness (Phase 2)Looking for participantsNCT07547930
What this trial is testing

Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease, TEDGraves OphthalmopathyGraves Orbitopathy
The First Affiliated Hospital of Xiamen University 8
Large-scale testing (Phase 3)Study completedNCT06106828
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Hoffmann-La Roche 127
Large-scale testing (Phase 3)Not Yet RecruitingNCT07620405
What this trial is testing

Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease (TED)
Minghui Pharmaceutical (Hangzhou) Ltd 219
Large-scale testing (Phase 3)Study completedNCT05524571
What this trial is testing

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Immunovant Sciences GmbH 86
Large-scale testing (Phase 3)Study completedNCT05517421
What this trial is testing

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Immunovant Sciences GmbH 114
Not applicableStudy completedNCT07471997
What this trial is testing

Triamcinolone Acetonide Injection for Upper Eyelid Retraction in Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease, TED
Instituto de Oftalmología Fundación Conde de Valenciana 15
Large-scale testing (Phase 3)Study completedNCT02155049
What this trial is testing

Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues

Who this might be right for
Thyroid Associated Ophthalmopathies
Rabin Medical Center 10
Early research (Phase 1)Looking for participantsNCT06569758
What this trial is testing

GenSci098 in Subjects With Active Thyroid Eye Disease

Who this might be right for
SafetyTolerabilityGenSci098+1 more
Changchun GeneScience Pharmaceutical Co., Ltd. 76
Post-approval studies (Phase 4)Not Yet RecruitingNCT07832136
What this trial is testing

An Open-Label Trial of Veligrotug in Participants With Thyroid Eye Disease Who Previously Responded to Teprotumumab

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 30
Next Page